A Phase I/II Clinical Study Using Pentamidine in Patients With Locally Advanced or Metastatic Pancreatic Cancer Undergoing Standard Therapy.
Phase of Trial: Phase I/II
Latest Information Update: 10 Jun 2011
At a glance
- Drugs Pentamidine (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Oncozyme Pharma
- 10 Jun 2017 Biomarkers information updated
- 10 Jun 2011 Actual end date (June 2011) added as reported by ClinicalTrials.gov.
- 10 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.